Enrique A. Conterno, Senior VP & President, Lilly Diabetes at LILLY ELI & CO (LLY), sold 5,000 shares at $53.79 ($269K) on 2013-08-15, disclosed to the SEC on 2013-08-16.
Scheduled sale ($269k) by Senior VP & President, Lilly Diabetes under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FGEN | SELL | 2023-04-11 | $36K | — | Filing → |
| FGEN | SELL | 2023-03-23 | $787K | — | Filing → |
| FGEN | SELL | 2023-03-10 | $1.7M | — | Filing → |